About this trial
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neuromodulation technology. This study will compare efficacy of different doses iTBS in combination with inhibitory rTMS on motor recovery and cortical excitability in subacute stroke patients.
Eligibility criteria
Qualifiers
1.Unilateral ischemic or hemorrhagic stroke
2.Stroke within 3 months
3.Medical Research Council Scale for Muscle Strength in upper limb ≤ 3
4.No previous stroke, seizure, dementia, Parkinson's disease or other degenerative neurological diseases.
Disqualifiers
1.Previous stroke, traumatic brain injury, brain tumor
2.With central nervous system disease (spinal cord injury, Parkinson's disease)
3.Any contraindication to rTMS (seizure, alcoholism, metal implant, pacemaker)
4.Patients unable to cooperate the treatment
Trial design
Treatments tested in this trial
- repetitive transcranial magnetic stimulation